An open, multicenter, phase I clinical study to evaluate the safety, efficacy and pharmacokinetics of HE006 tablets in the treatment of relapsed/refractory acute myeloid leukemia patients

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2022
This article has no abstract
Epistemonikos ID: 2049bc2d9f3387c7a29e27c90e36bf7608127ce6
First added on: Apr 08, 2025